ALN-AAT
ALN-AAT-001
Phase 1 small_molecule terminated
Quick answer
ALN-AAT for Antitrypsin Deficiency Liver Disease is a Phase 1 program (small_molecule) at ALNYLAM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Indication
- Antitrypsin Deficiency Liver Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated